DSCYX Performance — BNY Mellon Opportunistic Small Cap Fund, Class Y
Data updated: 2026-01-26
DSCYX returned +1.65% over one year to Nov 2025. Annualised returns are +6.09% over 3 years and +5.97% over 5 years. Against its US Small Blend category average the fund came out behind over three years but ahead over one: $100 invested three years ago grew to $119, against $132 for the category, and to $102 over one year, against $101. Volatility over the past three years was 19.90% a year. In the 12 months to Nov 2025 the fund lost a net $33.3M, and assets reached $227.62M.
DSCYX Growth of $100
What $100 invested in BNY Mellon Opportunistic Small Cap Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Small Blend category average over the same months.
| Period | DSCYX | Category average |
|---|---|---|
| 1 year (Dec 2024 – Nov 2025) | $102 | $101 |
| 3 years (Dec 2022 – Nov 2025) | $119 | $132 |
| 5 years (Dec 2020 – Nov 2025) | $134 | $150 |
| Since data start (Sep 2019 – Nov 2025) | $161 | $180 |
DSCYX Trailing Returns
Total returns to Nov 2025, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | +1.65% |
| 3 years (annualised) | +6.09% |
| 5 years (annualised) | +5.97% |
DSCYX Annual Returns
Calendar-year total returns of BNY Mellon Opportunistic Small Cap Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2025 (Jan–Nov) | +11.12% |
| 2024 | +3.97% |
| 2023 | +9.35% |
| 2022 | −17.28% |
| 2021 | +16.40% |
| 2020 | +19.35% |
| 2019 (Sep–Dec) | +10.99% |
DSCYX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | +4.8% | −5.3% | −5.8% | −3.6% | +6.0% | +7.6% | +0.6% | +5.6% | −1.1% | +0.1% | +2.7% | — |
| 2024 | −4.1% | +1.1% | +2.9% | −6.0% | +7.6% | −0.2% | +6.8% | +0.2% | +0.7% | −3.0% | +7.9% | −8.5% |
| 2023 | +12.1% | −2.8% | −6.2% | −2.8% | −1.1% | +8.9% | +5.2% | −4.8% | −6.8% | −7.7% | +7.7% | +10.0% |
| 2022 | −7.1% | +1.9% | +2.8% | −10.3% | +0.8% | −9.1% | +10.1% | −2.8% | −10.1% | +10.9% | +2.6% | −5.5% |
| 2021 | +3.0% | +7.7% | −0.3% | +3.8% | −0.8% | +1.6% | −2.2% | +1.6% | −2.4% | +4.3% | −3.8% | +3.4% |
| 2020 | −3.2% | −8.3% | −24.3% | +16.0% | +8.4% | +3.9% | +5.5% | +5.9% | −4.1% | −0.1% | +15.6% | +9.9% |
| 2019 | — | — | — | — | — | — | — | — | +2.7% | +1.2% | +3.7% | +2.9% |
DSCYX Risk
Risk measures from monthly returns over Dec 2022 – Nov 2025.
- 3-year volatility (annualised): 19.90%
- 3-year Sharpe ratio: 0.08 (vs 4.5% risk-free rate)
- Best month: +12.14% (Jan 2023)
- Worst month: −8.52% (Dec 2024)
DSCYX Fund Flows
Monthly money in and out of BNY Mellon Opportunistic Small Cap Fund, from SEC Form N-PORT.
- 12-month net flow: −$33.3M
- 12-month gross sales (incl. reinvestments): $4.7M
- Sales ÷ redemptions: 0.12×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Nov 2025 | $146K | $2.3M | −$2.2M |
| Oct 2025 | $324K | $2.5M | −$2.2M |
| Sep 2025 | $147K | $3.4M | −$3.2M |
| Aug 2025 | $333K | $2.1M | −$1.8M |
| Jul 2025 | $252K | $3.2M | −$3.0M |
| Jun 2025 | $146K | $2.6M | −$2.4M |
| May 2025 | $355K | $3.4M | −$3.0M |
| Apr 2025 | $388K | $3.8M | −$3.5M |
| Mar 2025 | $215K | $4.6M | −$4.4M |
| Feb 2025 | $266K | $2.7M | −$2.5M |
| Jan 2025 | $803K | $4.1M | −$3.3M |
| Dec 2024 | $1.3M | $3.3M | −$2.0M |
DSCYX Assets Under Management
Net assets of BNY Mellon Opportunistic Small Cap Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2025-11-30 | $227.62M |
| 2025-08-31 | $231.58M |
| 2025-05-31 | $209.31M |
| 2025-02-28 | $229.19M |
| 2024-11-30 | $262.10M |
| 2024-08-31 | $261.46M |
| 2024-05-31 | $274.33M |
| 2024-02-29 | $290.48M |
| 2023-11-30 | $293.43M |
| 2023-08-31 | $339.81M |
| 2023-05-31 | $320.86M |
| 2023-02-28 | $374.78M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.